CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 77 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99 | -34.4% | 231,952 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $151 | -99.9% | 231,952 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $198,000 | +55.9% | 231,952 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $127,000 | -50.4% | 231,952 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $256,000 | -40.2% | 231,952 | -7.1% | 0.00% | -50.0% |
| Q4 2021 | $428,000 | +172.6% | 249,792 | +385.5% | 0.00% | +100.0% |
| Q4 2020 | $157,000 | -34.3% | 51,450 | +30.8% | 0.00% | 0.0% |
| Q3 2020 | $239,000 | -73.6% | 39,340 | -74.3% | 0.00% | -75.0% |
| Q2 2020 | $905,000 | +217.5% | 153,109 | +42.1% | 0.00% | +100.0% |
| Q1 2020 | $285,000 | +4.0% | 107,778 | +6.9% | 0.00% | +100.0% |
| Q4 2019 | $274,000 | – | 100,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $6,156,000 | 0.40% |
| MFN Partners Management, LP | 3,389,215 | $2,915,000 | 0.13% |
| Diametric Capital, LP | 243,711 | $210,000 | 0.11% |
| Artal Group S.A. | 2,779,122 | $2,391,000 | 0.10% |
| Intrinsic Value Partners, LLC | 48,315 | $42,000 | 0.06% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 292,645 | $252,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $99,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 92,541 | $80,000 | 0.00% |
| COLONY GROUP LLC | 102,884 | $88,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 231,952 | $198,000 | 0.00% |